Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Hewitt

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
ACS Medicinal Chemistry Letters|January 20, 2022
Ulotaront: A TAAR1 Agonist for the Treatment of SchizophreniaMichele L R Heffernan, Lee W Herman, Scott Brown, et al.
Organic Letters|July 29, 2014
A practical synthesis of indoles via a Pd-catalyzed C-N ring formationRishi G Vaswani, Brian K Albrecht, James E Audia, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitorLiming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitorLiming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Journal of Medicinal Chemistry|July 12, 2011
Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analoguesLiming Shao, Michael C Hewitt, Scott C Malcolm, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitorsLiming Shao, Fengjiang Wang, Scott C Malcolm, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2015
Development of methyl isoxazoleazepines as inhibitors of BETMichael C Hewitt, Yves Leblanc, Victor S Gehling, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET BromodomainsAlexander M Taylor, Rishi G Vaswani, Victor S Gehling, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery, Design, and Optimization of Isoxazole Azepine BET InhibitorsVictor S Gehling, Michael C Hewitt, Rishi G Vaswani, et al.
Journal of Medicinal Chemistry|January 28, 2016
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical TrialsBrian K Albrecht, Victor S Gehling, Michael C Hewitt, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|January 20, 2022
Ulotaront: A TAAR1 Agonist for the Treatment of SchizophreniaMichele L R Heffernan, Lee W Herman, Scott Brown, et al.
Organic Letters|July 29, 2014
A practical synthesis of indoles via a Pd-catalyzed C-N ring formationRishi G Vaswani, Brian K Albrecht, James E Audia, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitorLiming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitorLiming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Journal of Medicinal Chemistry|July 12, 2011
Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analoguesLiming Shao, Michael C Hewitt, Scott C Malcolm, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitorsLiming Shao, Fengjiang Wang, Scott C Malcolm, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2015
Development of methyl isoxazoleazepines as inhibitors of BETMichael C Hewitt, Yves Leblanc, Victor S Gehling, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET BromodomainsAlexander M Taylor, Rishi G Vaswani, Victor S Gehling, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery, Design, and Optimization of Isoxazole Azepine BET InhibitorsVictor S Gehling, Michael C Hewitt, Rishi G Vaswani, et al.
Journal of Medicinal Chemistry|January 28, 2016
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical TrialsBrian K Albrecht, Victor S Gehling, Michael C Hewitt, et al.
Pageof 3